The SonR heart contractility sensor developed by Sorin can enable more patients to benefit from pacemakers, a trial has suggested. The 156-patient CLEAR study, sponsored by Sorin, has demonstrated that use of the technology to optimise cardiac resynchronisation therapy (CRT) reduced ...
Please Login to read the full article.
